---

🏫 EXPERT PG PEDIATRICS CLASSROOM LECTURE

ROSEOLA INFANTUM (EXANTHEM SUBITUM / SIXTH DISEASE)

A 120-Minute Evidence-Based Postgraduate Lecture

---

"Good morning, everyone. Before we begin, I want to ask you something. You are on night duty. A worried mother walks in at 2 AM with a 10-month-old infant who has had fever of 39.5°C for the past 3 days. Tonight, the fever broke. This morning, the baby is afebrile - and now covered in a rash from trunk to neck. The mother is terrified. What is your single most important clinical diagnosis? Yes - Roseola Infantum. And that is exactly what we are going to master today."

---

SECTION 1: INTRODUCTION

1.1 Definition

• High fever (38.9-40.6°C) lasting 3-5 days
• Abrupt defervescence followed within hours by
• Rose-pink maculopapular rash on the trunk, spreading centrifugally - appearing AFTER the fever resolves

---

1.2 Historical Background

"Who can tell me - who first described this disease? No? Let me tell you."

---

1.3 Synonyms

---

1.4 Why Is It Called the "Sixth Disease"?

"Residents, I always get asked this in viva. Know it cold."

---

SECTION 2: EPIDEMIOLOGY

2.1 Global Burden

• HHV-6 infection is essentially universal worldwide - no geographic exceptions.
• Seroprevalence reaches 80-95% by 2-3 years of age in all populations studied.
• In emergency clinics, HHV-6 accounts for 10-45% of all febrile illnesses in infants 6-12 months of age.
• About 20% of all ED visits for febrile children 6-12 months of age are attributable to HHV-6.

2.2 Incidence

• Only ~30% of children with primary HHV-6 infection develop the classic rash of roseola (exanthem subitum).
• The remaining 70% have undifferentiated febrile illness without rash or are subclinical.
• This is a key point - HHV-6 causes FAR more febrile illness than "roseola" alone.

2.3 Age Distribution

"If a 4-year-old presents with this picture, think twice. This disease has a narrow age window."

• Peak incidence: 6-21 months (some sources say 6-12 months as the single peak)
• 95% of cases occur between 6 months and 3 years
• Rare before 3 months (protected by maternal antibody)
• Rare after 4 years (most children already infected)
• Peak HHV-6 seroprevalence of 90-100% by 3-4 years
• Boys and girls equally affected (no sex predilection)

2.4 Maternal Antibody Dynamics - Pathognomonic Concept

"This is beautiful immunology. Let me draw this on the board."

Birth ——→ 3 months: High maternal IgG (protective)
3-6 months: Maternal IgG waning
6-12 months: NADIR of maternal IgG → PEAK susceptibility to HHV-6
12-24 months: Most children seroconvert
3-4 years: 90-100% seropositive

2.5 Seasonal Variation

• Infections occur throughout the year without strict seasonality (Red Book AAP).
• Spring has the highest incidence in some studies (Fitzpatrick's dermatology).
• Summer and fall epidemics have also been reported.
• HHV-7 infections tend to occur slightly later in childhood than HHV-6.

2.6 Risk Factors

• Waning maternal antibody (6-12 months)
• Daycare attendance (close contact with infected children/adults)
• Immunocompromised state (for severe disease/reactivation)
• Hematopoietic stem cell transplantation (HSCT) - reactivation in ~50% of recipients
• Cord blood transplant recipients - highest risk for limbic encephalitis

2.7 Transmission Dynamics

• Primary route: Respiratory secretions / saliva
• The salivary glands are an important site of viral replication and persistence
• Adults chronically shed HHV-6 in saliva - asymptomatically - and serve as the source of infection for infants (usually parents or older siblings)
• Older siblings are a particularly common source of transmission
• HHV-6 DNA also detected in cervix (potential perinatal route)
• NOT transmitted in breast milk
• In transplant settings: donor organ can transmit HHV-6 (rare)

2.8 Infectious Period

• HHV-6 is shed continuously in saliva by seropositive adults - no defined infectious period for the asymptomatic carrier
• During acute primary infection, viremia lasts 3-4 days
• Secondary cases are rarely identified - suggesting community exposure is the norm, not household transmission clusters

---

SECTION 3: ETIOLOGY AND VIROLOGY

3.1 Classification

• Family: Herpesviridae
• Subfamily: Betaherpesvirinae (most closely related to CMV)
• Genus: Roseolovirus (also includes HHV-7)
• Two formally distinct species: HHV-6A and HHV-6B (classified as separate species since 2012)

• Also a Roseolovirus, Betaherpesvirus
• ~50% DNA homology with HHV-6
• Isolated in 1990 from T lymphocytes of a healthy adult

3.2 HHV-6A vs HHV-6B - Important Differences

3.3 HHV-6 Virology

• Double-stranded DNA virus
• Genome: 160-170 kbp (kilobase pairs), G+C content 43-44%
• Genome organization resembles CMV
• Lipid envelope (making it susceptible to common disinfectants)
• Icosahedral capsid, tegument layer, envelope with glycoproteins

• CD46 (complement regulatory protein) - the primary cellular receptor for HHV-6
• This explains its tropism for CD4+ T lymphocytes (which express CD46)
• Also infects: CD8+ T cells, B cells, monocytes/macrophages, NK cells, astrocytes, microglia, oligodendrocytes, neurons

• HHV-6 is largely unrelated antigenically to other human herpesviruses
• Limited cross-reactivity exists between HHV-6 and HHV-7

3.4 Viral Replication

1. Attachment via glycoprotein H/L complex to CD46 receptor
2. Fusion with host cell membrane
3. Transport of capsid to nucleus
4. Lytic infection in activated CD4+ T lymphocytes: rapid replication, cytopathic effect
5. DNA replication using viral DNA polymerase
6. Virion assembly, tegument acquisition, envelopment
7. Release by exocytosis or cell lysis

3.5 Latency and Reactivation - A Critical Concept

"This is where HHV-6 gets really interesting - and clinically dangerous."

• After primary infection, HHV-6 establishes lifelong latency in:
  • CD4+ T lymphocytes (peripheral blood mononuclear cells)
  • Central nervous system
  • Salivary glands
  • Female genital tract
  • Lung

• HHV-6 can integrate its entire genome into telomeres of host chromosomes
• When this occurs in germline cells, offspring carry a copy in every nucleated cell
• ~1% of the general population has ciHHV-6 (inherited chromosomally integrated HHV-6)
• These individuals will always test PCR-positive for HHV-6 - a critical diagnostic pitfall!
• Pregnant women with ciHHV-6 may have higher risk of pre-eclampsia or spontaneous abortion (Harrison's 22E, 2025)

• Immunosuppression (transplantation, HIV, corticosteroids)
• Fever from other infections
• Pregnancy

• Immunocompetent: Usually asymptomatic
• Post-HSCT: Occurs in ~50% of patients, peaks 2-4 weeks post-transplant; can cause limbic encephalitis, delayed engraftment, increased mortality
• Solid organ transplant: Fever, rash, hepatitis, graft rejection

---

SECTION 4: PATHOGENESIS - STEP BY STEP

"Now we come to the most important part. If you understand pathogenesis, you understand every clinical feature. Follow me through this carefully."

Step 1: Viral Entry

• Route: Upper respiratory tract (infected saliva from an asymptomatic adult/older sibling)
• Virus binds to CD46 receptor on epithelial cells of oropharynx
• Initial replication occurs in oropharyngeal epithelium and regional lymph nodes (cervical, occipital)
• Clinical correlate: Mild pharyngitis, cervical/occipital lymphadenopathy seen early

Step 2: Initial Viremia (Primary Viremia)

• Virus spreads via lymphatics to blood
• Infects activated CD4+ T lymphocytes (its primary tropism)
• Also infects monocytes, macrophages, dendritic cells

Step 3: Secondary Viremia - Dissemination

• Viremia in immunocompetent children lasts 3-4 days
• Virus reaches: liver, spleen, salivary glands, CNS, skin
• Clinical correlate: Fever, hepatomegaly (mild), irritability

Step 4: The Fever Mechanism

• HHV-6 infects monocytes/macrophages and triggers release of:
  • IL-1β, TNF-α, IL-6 (major pyrogenic cytokines)
  • These act on the hypothalamic thermoregulatory center via prostaglandin E2 (PGE2)
• Fever is HIGH (39.5-40.6°C) because the cytokine response to primary HHV-6 is intense
• Fever is classically remittent (persists 3-5 days, peaks in early evenings)

"Ask yourself - why does the fever break so suddenly on day 3-5? Because the immune response - specifically CD8+ cytotoxic T cells and NK cells - clears the viremia. The moment viremia ends, the cytokine storm resolves, and temperature normalizes."

Step 5: The Immune Response

• Innate immunity: NK cells, type I interferons (IFN-α/β) provide early defense
• Adaptive immunity: CD8+ cytotoxic T cells - the primary clearance mechanism
• Antibody response: IgM appears within 5-7 days of infection; IgG follows
• As immune response matures → viremia clears → fever resolves → rash appears

Step 6: Why Does Rash Appear AFTER Defervescence? - The Key Pathogenic Question

"This is THE most important question in roseola pathogenesis. I guarantee this comes in your viva."

• The rash is an immune-mediated phenomenon - NOT direct viral cytopathic effect on skin
• When the adaptive immune response (CD8+ T cells) clears viremia, immune complexes and cytotoxic T-cell activity in dermal vessels cause a vasodilatory inflammatory response
• This produces the characteristic rose-pink maculopapules (similar to the mechanism in rubella)
• Since the rash requires mounting of adaptive immunity → it appears AFTER the fever (viremic phase) resolves
• This is analogous to other post-infectious exanthems

Step 7: Mechanism of Febrile Seizures

• HHV-6 is the single most common cause of febrile seizures in infancy (10-20% of all febrile seizures in infants are HHV-6-related)
• Mechanism is multifactorial:
  1. Rapid rise in temperature (rate of temperature change more important than absolute value)
  2. Direct neurotropism: HHV-6 infects astrocytes, microglia, neurons → direct CNS excitability
  3. Cytokine-mediated neuronal excitability: IL-6 lowers seizure threshold
  4. Transient neuronal hyperexcitability due to CNS inflammation
• This is why ~10-15% of roseola cases are complicated by febrile seizures (Red Book AAP)

Step 8: Why Children Recover Rapidly

• HHV-6 infection in immunocompetent children is self-limited because:
  • Rapid and effective innate immune response (interferon, NK cells)
  • Brisk CD8+ T-cell response clears viremia efficiently
  • Antibody seroconversion provides durable protection against reinfection
  • The virus retreats into latency after primary viremia is cleared

---

SECTION 5: CLINICAL FEATURES

The Classic Biphasic Course

Day 0-1:     Abrupt onset high fever (39.5-40.6°C)
Days 1-3:    Persistent high fever; child may be surprisingly well-appearing
             Associated: irritability, rhinorrhea, mild diarrhea
Day 3-5:     ABRUPT DEFERVESCENCE (fever breaks suddenly)
Hours later: RASH APPEARS (erythematous maculopapular, trunk-first)
Days 5-7:    Rash fades; child completely recovered

"Remember: 'Rose after the fever goes.' That is roseola."

5.1 The Fever

• Temperature: 38.9-40.6°C (102-105°F) - often alarmingly high
• Pattern: Remittent; tends to peak in early evenings
• Duration: 3-5 days (some sources say 3-7 days)
• Quality: Child often looks surprisingly well despite high fever - "happy, active, playful, alert" (Leung et al., 2024)
• Important: The fever is the stage of viremia; child is most contagious during this phase

5.2 The Rash

5.3 Associated Symptoms - Mechanism for Each

• Caused by high-grade fever + direct CNS involvement (neurotropism of HHV-6)
• Children may be difficult to soothe during the febrile phase
• EXAM POINT: Despite high fever, children are often "alert and active" - this reassures against serious bacterial infection

• HHV-6 infects intestinal epithelium → mild mucosal inflammation
• Self-limited, watery, non-bloody
• Occurs in ~68% of primary HHV-6 infections (Asano et al., 1994)

• Mild upper respiratory tract inflammation
• Reflects viral replication in oropharyngeal mucosa

• Mild injection of conjunctivae
• Palpebral (eyelid) edema - gives a "sleepy appearance" - characteristic sign in roseola (Fitzpatrick's)

• Site of initial viral entry and replication

• Cited in the Red Book AAP - a common but underappreciated finding
• TRAP: Can mislead residents into diagnosing otitis media and prescribing antibiotics unnecessarily!

5.4 NAGAYAMA SPOTS - High-Yield Sign

"How many of you know Nagayama spots? Let me teach you. This is frequently asked in viva and PG exams."

• Erythematous red papules on the soft palate and uvula
• Also: Ulcers at the uvula and palatoglossal junction (pathognomonic finding, per Dermatology 2-Volume Set 5e)
• Described by Dr. Nagayama in Japan
• Present in many but not all cases
• They may PRECEDE the skin exanthem - thus can serve as an early diagnostic clue before the rash appears
• Distinct from Koplik spots of measles (which are bluish-white on a red base on buccal mucosa)

5.5 Bulging Anterior Fontanelle

• Seen in some infants with roseola
• Mechanism: Mild aseptic meningeal irritation and increased intracranial pressure from cytokine-mediated CNS inflammation
• NOT always indicative of bacterial meningitis - context matters!
• In the presence of roseola, a bulging fontanelle usually resolves spontaneously
• Clinical pearl: Always perform LP to rule out bacterial meningitis if fontanelle is tense and child is toxic - do NOT assume roseola without ruling out serious bacterial infection

5.6 Cervical and Occipital Lymphadenopathy

• Common finding during febrile phase
• Occipital lymphadenopathy is particularly associated with roseola (also with rubella)
• Post-occipital lymphadenopathy was described as a diagnostic sign by McEnery (1970)
• Reflects initial replication in cervical lymph nodes

5.7 Febrile Seizures

• Occur in 10-15% of children with primary HHV-6 infection (Red Book AAP; Dermatology 5e)
• HHV-6 accounts for 10-20% of all febrile seizures during infancy (Harrison's 22E, 2025)
• Usually occur during the febrile phase (not after rash appears)
• Most are simple febrile seizures: generalized, <15 minutes, single episode
• Complex febrile seizures (prolonged, focal, or multiple within 24 hours) can occur
• Seizures can precede the rash - making diagnosis retrospective

---

SECTION 6: PHYSICAL EXAMINATION

"Let me walk you through how I examine a child I suspect has roseola. This is bedside teaching."

6.1 General Inspection (From the Door)

• Overall appearance: Alert, active, playful (despite fever) OR irritable
• Hydration status: Assess capillary refill, skin turgor, mucous membranes, fontanelle
• Note: A "happy" febrile infant - think roseola

6.2 Vital Signs

• Temperature: Rectal temperature preferred for accuracy in infants <3 months (axillary acceptable for older infants)
• Heart rate: Tachycardia proportional to fever
• Respiratory rate: Count for a full minute
• Blood pressure: Check if appears toxic

6.3 Skin Examination

• Inspect trunk first (undress the child completely)
• Note: Rose-pink discrete macules/papules, 2-5mm, with white halo
• Check neck, proximal extremities, face
• Blanching test: Press with a glass slide (diascopy) - if it blanches → vasodilatory/inflammatory rash; if non-blanching → purpuric → ALARM SIGN (think meningococcemia, HSP)
• Note absence of desquamation, absence of vesicles, absence of petechiae/purpura

6.4 Lymph Node Examination

• Palpate cervical (anterior + posterior), occipital, submandibular chains
• Occipital + posterior cervical nodes enlarged → supports roseola/rubella
• Note: size, tenderness, consistency, overlying skin changes

6.5 Oral Cavity (VERY IMPORTANT)

• Look for: Nagayama spots on soft palate, uvula
• Koplik spots? → Think measles
• Strawberry tongue? → Think scarlet fever, Kawasaki
• Oral ulcers at palatoglossal junction → supports roseola
• Check pharynx for erythema, exudate

6.6 Neurological Examination

• Assess fontanelle: flat/bulging/tense
• Neck stiffness: Kernig's + Brudzinski's (if meningeal signs present → LP)
• Level of consciousness: AVPU scale or GCS
• Look for focal deficits
• Post-ictal state if seizure occurred

6.7 Ear Examination

• Otoscopy: Injected tympanic membranes (common in roseola - do NOT automatically prescribe antibiotics)
• Assess for signs of true AOM: loss of light reflex, bulging, effusion

6.8 Abdominal Examination

• Palpate for hepatomegaly (mild; present in ~10% with acute HHV-6 infection)
• Splenomegaly: Uncommon in uncomplicated roseola

6.9 Red Flag Findings (Admit/Urgent Workup)

---

SECTION 7: CLASSICAL CLINICAL SCENARIO

"Let me present a case. This is exactly how you will be tested in an OSCE or final examination."

Case Presentation

"What are you thinking? Roseola! Now let me take you through the examination."

• Vitals: Afebrile, HR 110/min, RR 30/min, SpO2 99%
• Skin: Discrete rose-pink maculopapules, 2-4mm, blanching on pressure, with white halos; present on trunk, neck, proximal extremities; face mildly involved. No petechiae. No desquamation.
• Lymph nodes: Bilateral posterior cervical and occipital lymph nodes palpable (0.5-1cm), soft, non-tender
• Oral: Erythematous papules on soft palate (Nagayama spots)
• ENT: Mild pharyngeal congestion; tympanic membranes mildly injected bilaterally
• Fontanelle: Flat (normal)
• Neurological: No neck stiffness; Kernig's/Brudzinski's negative; normal tone, reflexes
• Abdomen: Soft; liver just palpable (1cm below right costal margin, normal for age)

"This is a textbook case. What is your diagnosis? Exanthem Subitum / Roseola Infantum. No investigations needed. Management: Parental reassurance, symptomatic treatment."

• "Your child has a viral illness called Roseola. The fever has broken. The rash appeared because the body's immune system is now fighting the virus successfully - this is actually a GOOD sign."
• "The rash will disappear on its own in 1-2 days without any treatment."
• "Continue oral feeds; paracetamol if uncomfortable; return if seizure occurs, rash becomes dark/non-blanching, child becomes very lethargic, or fever returns."

---

SECTION 8: DIFFERENTIAL DIAGNOSIS

"This section will be crucial for your clinical practice and examination. Let me build a comparison table for you."

8.1 Comprehensive Differential Diagnosis Table

8.2 Memory Aid for Rash Timing

BEFORE fever / during prodrome: Koplik spots (measles)
DURING fever with rash:         Measles, Scarlet fever, Dengue, Drug rash, Kawasaki
AFTER fever resolves:           ROSEOLA (Exanthem Subitum) ← UNIQUE

---

SECTION 9: DIAGNOSIS

9.1 Clinical Diagnosis - The Gold Standard

"In the vast majority of cases - roseola is a CLINICAL diagnosis. No tests needed."

1. Age 6 months - 3 years
2. High fever (≥38.5°C) for 3-5 days
3. Abrupt defervescence
4. Rose-pink maculopapular rash appearing AFTER fever resolves
5. Otherwise well-appearing child
6. Nagayama spots (if present, strongly supportive)
7. Occipital/cervical lymphadenopathy

9.2 When Investigations ARE Unnecessary

• Typical presentation with above criteria
• Immunocompetent child
• No complications
• Rash has appeared (confirming diagnosis retrospectively)

9.3 CBC Findings

9.4 Other Lab Parameters

9.5 Specific Laboratory Diagnosis (When Needed)

• Immunocompromised patients (transplant, HIV, malignancy)
• Severe/atypical presentation
• Encephalitis workup
• Epidemiological purposes
• ciHHV-6 detection

• Quantitative real-time PCR is the test of choice for active infection
• Detects HHV-6 DNA in:
  • Peripheral blood (PBMC) - most common
  • CSF (for encephalitis evaluation)
  • Tissue biopsies
• Qualitative PCR CANNOT distinguish: latent vs active infection
• Quantitative PCR: HIGH viral load = active/replicating infection; low/undetectable = latent
• ciHHV-6 pitfall: Very high viral load (~10⁶ copies/whole blood) in all samples → suspect ciHHV-6

• IgM: Appears within 5-7 days; BUT IgM is NOT reliable - may not be detectable in all primary infections, and can be positive in asymptomatic adults (due to reactivation)
• IgG: Fourfold rise from acute to convalescent (2-4 weeks apart) = evidence of recent primary infection
• IgG avidity testing: Low-avidity IgG → recent primary infection; useful to distinguish from reactivation
• Cross-reactivity between HHV-6 and HHV-7 serology

• Possible in CD4+ T lymphocytes or saliva
• Low sensitivity, long turnaround (3-4 weeks), expensive
• Rarely used clinically (Red Book AAP)

• FDA-cleared panels include HHV-6 as a target for CSF
• Important caveat: A positive HHV-6 result may represent ciHHV-6 in the 1% of population with chromosomal integration - must interpret with clinical context and high viral loads

9.6 Summary Table: When to Test

---

SECTION 10: MANAGEMENT

"Management of roseola is largely about what NOT to do - don't over-investigate, don't over-treat, and don't under-counsel the parents."

10.1 Outpatient Management (Majority of Cases)

• Paracetamol (Acetaminophen): 10-15 mg/kg/dose every 4-6 hours (max 5 doses/24h) - FIRST LINE
• Ibuprofen: 5-10 mg/kg/dose every 6-8 hours - Alternative (avoid <6 months, avoid in dengue possibility)
• Luke-warm sponging: Adjunct; tepid water (not cold, not ice)
• Do NOT use aspirin (Reye's syndrome risk)
• Do NOT use aspirin in any viral illness in children

• Encourage oral fluids: ORS, breast milk, formula, water
• Continue feeds; anorexia is temporary
• If vomiting/poor intake → IV fluids if hospitalized

• No specific isolation required for typical roseola in immunocompetent children
• Child can return to daycare once fever-free for 24 hours
• No exclusion required once asymptomatic (virus continues to be shed in saliva for life, so isolation beyond fever is impractical)

• No antiviral is indicated for uncomplicated roseola in immunocompetent children (StatPearls, Red Book AAP)
• No vaccine currently available

10.2 Parent Counselling - Key Points

"This is an OSCE station. You will be scored on communication."

1. Explain the diagnosis: "Your child has a viral illness called Roseola. It is very common in infants this age."
2. Explain the rash: "The rash appearing AFTER the fever is NOT an allergic reaction. It is actually a sign that your baby's immune system has successfully fought the virus. It will go away on its own in 1-2 days."
3. Prognosis: "This is a self-limiting illness. Your child will recover completely."
4. Return to clinic if:
   • Seizure occurs
   • Rash becomes dark/non-blanching (red alarm: meningococcemia)
   • Child becomes very lethargic, difficult to arouse
   • Fever returns after resolution
   • Child is not tolerating fluids
   • Rash does not fade within 5 days
5. Fever management at home: Explain antipyretic dosing and schedule
6. Daycare: Can return when fever-free for 24 hours
7. Siblings: Explain that other young children in the home may develop similar illness

10.3 Hospital Admission Criteria

---

SECTION 11: FEBRILE SEIZURES IN ROSEOLA

"This is a standalone chapter in any pediatrics textbook, but let me contextualize it for roseola."

11.1 Epidemiology

• HHV-6 is responsible for 10-20% of all febrile seizures in infants (Harrison's 22E, 2025)
• Febrile seizures occur in 10-15% of children with roseola (Red Book AAP; Leung et al. 2024)
• Age: predominantly 6-18 months (peak risk)
• Risk with genetic mutations: RandBP2, POLG, CPT2 mutations predispose to severe neurological disease with HHV-6 (Red Book AAP)

11.2 Classification

"In roseola, most seizures are SIMPLE. If you see a complex febrile seizure - always consider HHV-6 encephalitis or a genetic predisposition."

11.3 Initial Management of Febrile Seizure

Step 1: ABC - Position (recovery position), O2, venous access
Step 2: Assess duration (time the seizure from onset)
Step 3: If seizure >5 minutes → TREAT (don't wait for 15 minutes)
Step 4: First-line drug → IV/IM/buccal/rectal Benzodiazepine
   → IV Diazepam: 0.3 mg/kg IV (max 10mg)
   → Buccal/intranasal Midazolam: 0.2-0.3 mg/kg (preferred if no IV access)
   → Rectal Diazepam: 0.5 mg/kg
Step 5: If no response in 5-10 min → REPEAT benzodiazepine
Step 6: If refractory (status epilepticus) → IV Phenobarbitone 20 mg/kg 
        or IV Phenytoin 20 mg/kg (or Fosphenytoin 20 PE/kg)
Step 7: Treat underlying fever with antipyretics
Step 8: Identify cause - roseola context → reassure if typical

11.4 When to Do Lumbar Puncture (LP)

11.5 Neuroimaging - When Is It Required?

• NOT required for simple febrile seizure
• MRI brain indicated when:
  • Focal neurological signs
  • Prolonged postictal state (>30-60 min)
  • Focal seizure
  • Encephalopathy persisting after seizure
  • Suspicion of HHV-6 encephalitis (especially in immunocompromised - look for mesial temporal signal changes on MRI)

11.6 EEG Indications

• NOT required after simple febrile seizure
• Indicated if:
  • Concern for epileptic disorder (afebrile seizures, atypical febrile seizures)
  • Complex febrile seizure
  • Encephalitis evaluation

11.7 Prophylaxis After Febrile Seizure

• NOT recommended for simple febrile seizures (AAP Position Statement)
• Parents should be counselled on home management (rectal/buccal diazepam for prolonged seizures)
• Continuous antiepileptic drugs NOT routinely recommended

---

SECTION 12: COMPLICATIONS

12.1 In Immunocompetent Children

12.2 In Immunocompromised Patients - Severe Disease

"This is where roseola stops being benign. HHV-6 in transplant patients is life-threatening."

12.3 Hemophagocytic Lymphohistiocytosis (HLH) - Important

• HHV-6 is a recognized trigger of secondary HLH
• Suspect HLH if: Prolonged fever + cytopenias + splenomegaly + hyperferritinemia + elevated triglycerides + reduced NK activity
• HLH-2004 criteria (5 of 8): Fever, splenomegaly, bicytopenia, hypertriglyceridemia/hypofibrinogenemia, hemophagocytosis on BM biopsy, low/absent NK activity, elevated ferritin (>500), elevated sCD25

---

SECTION 13: SPECIAL SITUATIONS

13.1 Neonates (<3 Months)

• Roseola is rare due to maternal antibody protection
• Any febrile neonate (<28 days) → full sepsis workup (CBC, blood culture, LP, CXR, urine culture) regardless of suspected viral etiology
• HHV-6 can rarely cause neonatal sepsis-like picture
• Congenital HHV-6 occurs (see below)

13.2 Congenital HHV-6 Infection

• Occurs in ~1% of newborns (Red Book AAP; Harrison's 22E)
• Two mechanisms:
  1. ciHHV-6: Germline passage of chromosomally integrated HHV-6 from parent (most common - ~86%)
  2. Transplacental infection: From active maternal primary infection or reactivation
• Usually asymptomatic
• Some reports of subtle neurologic defects
• Harrison's 22E (2025): Women with ciHHV-6 may have higher risk of pre-eclampsia or spontaneous abortion
• Diagnostic challenge: ciHHV-6 infants will always test PCR-positive - must use quantitative/droplet digital PCR + parental testing to differentiate from active infection

13.3 HIV-Infected Children

• In vitro: HHV-6 may both increase AND decrease HIV-1 replication depending on conditions
• No definitive evidence that HHV-6 accelerates HIV disease progression (Dermatology 5e)
• However: HHV-6 reactivation more likely with CD4+ depletion

13.4 Transplant Recipients

• HHV-6 reactivation in ~50% (peak 2-4 weeks post-transplant)
• Higher risk: Allelic-mismatched donors (haploidentical, cord blood), glucocorticoid use
• Monitor with quantitative blood PCR
• Treatment (Red Book AAP): Ganciclovir/valganciclovir or foscarnet for symptomatic HHV-6 disease; specifically recommended for HHV-6 encephalitis in HSCT/solid organ transplant
• Antiviral resistance can occur

• HHV-6 from donor organ (rare)
• Reactivation causing fever, hepatitis, graft dysfunction

13.5 Pregnancy

• HHV-6 reactivation common in pregnancy
• ciHHV-6 in pregnant women: Possible higher risk of pre-eclampsia, spontaneous abortion (Harrison's 22E 2025 - recent finding requiring further study)
• Congenital infection via transplacental route possible

---

SECTION 14: PROGNOSIS

• Immunocompetent children: Excellent prognosis; complete recovery within 1 week
• Fever resolves in 3-7 days; rash fades in 1-5 days without sequelae
• No long-term neurological deficits from uncomplicated roseola
• No recurrence (lifelong immunity after primary infection in most)
• Latency: HHV-6 persists lifelong in latent state in CD4+ T cells, CNS, salivary glands; asymptomatic in immunocompetent individuals
• Immunocompromised: Guarded prognosis depending on severity of reactivation disease; limbic encephalitis in HSCT carries significant morbidity/mortality

---

SECTION 15: PREVENTION

15.1 Infection Control

• Hand hygiene: Handwashing with soap and water - most effective measure
• Respiratory etiquette: Cover coughs/sneezes; avoid sharing utensils/saliva
• HHV-6 is enveloped → susceptible to standard disinfectants (alcohol-based sanitizers, soap)

15.2 Daycare Precautions

• Exclude from daycare until fever-free for 24 hours
• No prolonged exclusion needed (virus shed asymptomatically in saliva by adults anyway)
• Clean surfaces and toys regularly

15.3 Vaccine Status

• No vaccine available for HHV-6 or HHV-7 as of 2026
• Research into HHV-6 vaccines is ongoing
• MMR vaccine indirectly protects against measles and rubella (important differentials)

15.4 Antiviral Prophylaxis

• Not routinely recommended for immunocompetent individuals
• Ganciclovir prophylaxis may prevent HHV-6 reactivation in high-risk BMT patients (reported in literature; further double-blind trials needed per Medscape)

---

SECTION 16: 40 VIVA QUESTIONS WITH ANSWERS

"These are questions that senior examiners at DM Pediatrics and MD finals ask. Learn every answer."

---

SECTION 17: OSCE STATIONS

Station 1: History Taking (7 minutes)

• Seizure? (Duration, type, recovery)
• Non-blanching rash?
• Decreased level of consciousness?
• Stiff neck?
• Poor feeding/decreased urine output (dehydration)?

---

Station 2: Physical Examination (7 minutes)

1. Wash hands, introduce yourself, explain to "parent" (examiner)
2. General inspection: Appearance (alert/toxic), hydration, rash visible?
3. Vital signs: Temperature, HR, RR, SpO2 (state you would check these)
4. Skin: Undress completely; describe rash (morphology, distribution, 
         blanching test with glass slide)
5. Head: Anterior fontanelle (flat/bulging/tense), scalp
6. Eyes: Conjunctivitis? Palpebral edema?
7. Ears: Otoscopy - tympanic membranes
8. Oral cavity: Nagayama spots on soft palate, uvula; Koplik spots?;
               Strawberry tongue?; Pharynx
9. Lymph nodes: Occipital, posterior cervical, anterior cervical, 
                submandibular, inguinal
10. Respiratory: Auscultation
11. Cardiovascular: Heart sounds, pulse
12. Abdomen: Hepatomegaly, splenomegaly
13. Neurology: Neck stiffness (Kernig's, Brudzinski's), tone, reflexes
14. Summarize findings to examiner

---

Station 3: Rash Identification Station (5 minutes)

---

Station 4: Parent Counselling (7 minutes)

---

SECTION 18: 30 CLINICAL PEARLS

"These pearls have been forged over 30 years at the bedside. Write them down."

1. "Rose after the fever goes" - the single most memorable fact about roseola.
2. The Happy Febrile Infant: A child with temperature 40°C who is smiling and alert → think roseola; the same child appearing toxic → think serious bacterial infection.
3. Nagayama spots before the rash: Look in the mouth of every febrile infant. Soft palate papules may be your early clue to diagnose roseola before the rash appears.
4. Leukopenia in a febrile infant: When CBC shows WBC <4,000 with relative lymphocytosis in a 6-24-month-old with high fever - strongly suggests HHV-6.
5. The "injected TM trap": Inflamed tympanic membranes in roseola do NOT mean bacterial otitis media. Check clinical context before prescribing antibiotics.
6. Rash + defervescence = reassurance: When a febrile child develops rash as the fever breaks, parents are often terrified. Explain that this is the best possible sign - the fever has cleared and the immune system has "won."
7. ciHHV-6 trap: If a PCR shows very high HHV-6 DNA (close to 1 copy per cell) in all samples including CSF - suspect chromosomal integration, not active encephalitis.
8. HHV-6 is the #1 cause of febrile seizures: Every time a resident says "it's just a febrile seizure" - remember that HHV-6 is directly neurotropic and can cause encephalitis. The decision to do LP must be individualized.
9. Rash duration <48 hours: If you see a child with a pinkish truncal rash that their parents said was present 3 days ago but is now fading - you may be seeing roseola resolving. History of preceding fever is the key.
10. No antiviral, no antibiotic, no steroid: Uncomplicated roseola needs none of these. The management is education, antipyretics, hydration.
11. HHV-6 in transplant patients = emergency: Post-HSCT fever at 2-4 weeks should always trigger HHV-6 PCR monitoring. Delay in diagnosis of limbic encephalitis worsens outcome.
12. Ganciclovir/foscarnet, NOT acyclovir: Unlike HSV/VZV where acyclovir works, HHV-6 has minimal sensitivity to acyclovir. Always use ganciclovir or foscarnet for HHV-6 disease.
13. Seasonal peak in spring: Important for epidemiological context in exams.
14. Cord blood transplant = highest risk for PALE: Among HSCT subtypes, cord blood recipients have highest risk of post-transplant acute limbic encephalitis.
15. Mothers' saliva is the source: Caregivers asymptomatically shed HHV-6 in saliva throughout life. Telling parents "where it came from" - it came from them (or older siblings), and that is normal.
16. The palpebral edema sign: Eyelid edema giving a "sleepy appearance" in an otherwise alert febrile infant → characteristic of roseola (Fitzpatrick's).
17. Rash starts on trunk, not face: Unlike measles (starts at hairline/face), scarlet fever (neck/trunk), rubella (face first) - roseola rash is TRUNK-FIRST.
18. MRI mesial temporal signal: In any post-transplant patient with HHV-6 + confusion/amnesia/seizures → MRI showing hippocampal signal = PALE until proven otherwise.
19. HHV-6 and MS: HHV-6 (like EBV) has been implicated in the pathogenesis of multiple sclerosis, though the association vs causation remains to be established (Harrison's 22E 2025).
20. Seroprevalence is NOT immunity to disease: In adults, high HHV-6 seroprevalence means latent infection, but reactivation in immunocompromised individuals can cause life-threatening disease.
21. Never diagnose roseola in a neonate: A febrile neonate (<28 days) gets a full sepsis workup regardless. Roseola is rare before 3 months.
22. LP in infant <12 months with first febrile seizure: Always consider - meningeal signs are subtle or absent in this age group.
23. Roseola rash is non-pruritic: If itching is prominent, think drug rash, viral exanthem other than roseola, or urticaria.
24. RandBP2 and POLG mutations: Children with these mutations who get HHV-6 infection can develop severe encephalopathy - a genetic susceptibility link (Red Book AAP).
25. Hepatomegaly in roseola: Mild, transient. If hepatomegaly is prominent with raised transaminases → think HLH, other viral hepatitis (EBV, CMV, adenovirus).
26. HHV-7 roseola is lighter: The rash in HHV-7-induced exanthem subitum is lighter in color and appears later in the disease course than HHV-6 infection (Dermatology 5e).
27. Antipyretic choice in dengue-endemic areas: Use paracetamol; AVOID ibuprofen (NSAIDs increase bleeding risk in dengue). In any febrile child where dengue is possible → paracetamol only until dengue ruled out.
28. The white halo sign: Discrete rose-red maculopapule surrounded by a pale halo = essentially pathognomonic for roseola.
29. HHV-6 encephalitis in immunocompetent adult: Increasingly recognized; consider in adult with temporal lobe encephalitis of unknown cause (PMID 39301106).
30. The retrospective diagnosis: In practice, you often diagnose roseola retrospectively - a child seen during the febrile phase, sent home with "viral fever," returns with a rash after fever has broken. Connecting these two visits makes the diagnosis.

---

SECTION 19: COMMON MISTAKES BY RESIDENTS

"In 30 years, I have seen the same mistakes made repeatedly. Learn from others' errors."

---

SECTION 20: RECENT ADVANCES (2021-2026)

"Let me briefly cover what is new in the last 5 years - important for your research awareness."

• Curr Pediatr Rev 2024;20(2):119-128
• Comprehensive updated review confirming all classical clinical features
• Emphasizes that failure to recognize roseola leads to unnecessary investigations, misuse of healthcare expenditure, and delayed treatment of mimickers

• New concern: Women with ciHHV-6 may have higher risk of pre-eclampsia or spontaneous abortion
• Reinforces importance of distinguishing ciHHV-6 from active infection

• Webb et al., Open Forum Infect Dis 2024
• HHV-6 encephalitis increasingly recognized in immunocompetent adults (not just transplant patients)
• Review of diagnostic challenges and management

• Droplet digital PCR now preferred over standard qPCR for ciHHV-6 identification
• Germline integration of HHV-6A is actually more common than HHV-6B integration in general population

• HHV-6 (particularly HHV-6A) along with EBV being actively studied in MS pathogenesis
• Molecular mimicry and myelin destruction pathways being investigated

• HHV-6 (plus EBV, CMV, HHV-7) reactivation confirmed as driver of drug reaction with eosinophilia and systemic symptoms (DRESS) - important in the immunocompromised and drug-exposed

• RandBP2 and POLG mutations increasingly recognized as predisposing to severe HHV-6 CNS disease - potential for genetic screening in severely affected children

---

SECTION 21: SUMMARY AND REVISION AID

21.1 Key Take-Home Messages

1. Roseola infantum = high fever (3-5 days) + rash appearing AFTER defervescence in a 6-24-month infant
2. HHV-6B is the primary cause; 30% of primary HHV-6 infections show the classic rash
3. The child appears happy and active despite high fever
4. Leukopenia is characteristic on CBC
5. Nagayama spots (soft palate red papules) are a diagnostic clue
6. Management is supportive; no antiviral for uncomplicated disease
7. HHV-6 is the #1 cause of febrile seizures in infancy
8. ciHHV-6 (in 1% of population) always tests PCR-positive - a diagnostic pitfall
9. In immunocompromised patients (especially HSCT), HHV-6 reactivation is serious - treat with ganciclovir/foscarnet
10. The rash is immune-mediated - reassure parents it is a good sign

---

21.2 MNEMONICS

• R - Rose-pink rash (trunk-first, after fever)
• O - Occipital lymphadenopathy
• S - Sixth disease / Sudden fever
• E - Exanthem Subitum
• O - Only 30% show classic rash (70% undifferentiated fever)
• L - Leukopenia (characteristic CBC)
• A - Age 6-24 months (peak)

---

• S - Sixth disease
• I - Infant (6-24 months)
• X - eXanthem Subitum
• C1 - Chromic (lifelong latency)
• C2 - CD4+ T cell tropism; CD46 receptor
• C3 - Clears fever first, THEN rash appears

---

• M - Measles (rash DURING fever, cephalocaudal, Koplik)
• A - Adenovirus (pharyngoconjunctival fever)
• D - Dengue (thrombocytopenia, biphasic fever)
• E - Enteroviral exanthem (HFMD, oral ulcers)
• S - Scarlet fever (sandpaper rash, strawberry tongue)
• R - Roseola (rash AFTER fever)
• P - Parvovirus B19 (slapped cheek)

---

21.3 DIAGNOSTIC ALGORITHM

                    FEBRILE INFANT 6-24 MONTHS
                            │
                    ┌───────┴───────┐
               Fever present    Fever resolved
               (days 1-5)        + Rash appeared
                    │                   │
          Leukopenia on CBC?      ROSEOLA INFANTUM
          Nagayama spots?               │
          Happy, active?          No investigations
                    │              needed (typical)
               Consider HHV-6          │
             (clinical diagnosis)  Reassure parents
                    │              Antipyretics PRN
          ┌─────────┴─────────┐
     Febrile seizure?    Rash non-blanching?
          │                   │
    Simple or complex?   EMERGENCY - rule out
          │               meningococcemia
     Simple: reassure
     Complex: LP, EEG, 
     neuroimaging if indicated

---

21.4 MANAGEMENT ALGORITHM

DIAGNOSIS: ROSEOLA INFANTUM (Typical Presentation)
                │
    ┌───────────┴───────────┐
Immunocompetent child    Immunocompromised child
    │                         │
OUTPATIENT                  ADMIT
    │                         │
Paracetamol 10-15 mg/kg   HHV-6 PCR (quantitative)
  q4-6h PRN fever          LFTs, CBC, metabolic panel
Oral hydration             Consider ganciclovir/
Parent counselling          foscarnet
Return precautions         Organ-specific workup
No antiviral               Infectious disease consult
No antibiotics
No isolation
    │
Febrile seizure occurs?
    │
Assess: Simple vs Complex
    │
Simple → No LP (if >18 months, typical roseola)
       → Rectal/buccal diazepam at home
       → Parent seizure education
       │
Complex or infant <12 months → Consider LP
                              → Neuroimaging if focal Sx
                              → Admit for observation

---

21.5 ONE-PAGE REVISION SHEET

╔══════════════════════════════════════════════════════════════════════╗
║              ROSEOLA INFANTUM - HIGH YIELD SUMMARY                  ║
╠══════════════════════════════════════════════════════════════════════╣
║ CAUSE    │ HHV-6B (primary); HHV-7 (secondary)                       ║
║ AGE      │ 6-24 months (peak); 95% cases in <3 years                 ║
║ SEASON   │ Spring (highest); year-round                              ║
║ RECEPTOR │ CD46 on CD4+ T cells                                      ║
╠══════════════════════════════════════════════════════════════════════╣
║ CLINICAL │ Fever (39.5-40.6°C) × 3-5 days → ABRUPT defervescence     ║
║          │ → Rose-pink maculopapular TRUNK-FIRST rash (2-5mm)        ║
║          │ → White halo sign (pathognomonic)                         ║
║          │ → Happy, active child despite high fever                  ║
╠══════════════════════════════════════════════════════════════════════╣
║ SIGNS    │ Nagayama spots (soft palate); Occipital LAP               ║
║          │ Palpebral edema; Injected TMs; Bulging fontanelle (mild) ║
╠══════════════════════════════════════════════════════════════════════╣
║ CBC      │ LEUKOPENIA + relative LYMPHOCYTOSIS                       ║
╠══════════════════════════════════════════════════════════════════════╣
║ COMPLICATIONS │ Febrile seizures (10-15%) ← MOST COMMON              ║
║               │ Encephalitis (rare in immunocompetent)               ║
║               │ HLH, hepatitis, pneumonitis (very rare)              ║
║               │ IMMUNOCOMPROMISED: PALE (limbic encephalitis),       ║
║               │ bone marrow suppression, graft rejection             ║
╠══════════════════════════════════════════════════════════════════════╣
║ TREATMENT │ SUPPORTIVE - Paracetamol, oral hydration                 ║
║           │ NO antiviral, NO antibiotic (uncomplicated)              ║
║           │ Immunocompromised → Ganciclovir/Foscarnet                ║
╠══════════════════════════════════════════════════════════════════════╣
║ ciHHV-6  │ 1% of population; always PCR+; NOT active infection       ║
╠══════════════════════════════════════════════════════════════════════╣
║ PROGNOSIS│ Excellent; complete recovery; lifelong immunity           ║
╠══════════════════════════════════════════════════════════════════════╣
║ REMEMBER │ "ROSE after the fever GOES"                               ║
║          │ Only 30% of HHV-6 infections show classic rash            ║
║          │ HHV-6 = #1 cause of febrile seizures in infancy          ║
╚══════════════════════════════════════════════════════════════════════╝

---

21.6 PG ENTRANCE AND DM PEDIATRICS HIGH-YIELD FACTS

---

SOURCES

• Harrison's Principles of Internal Medicine, 22nd Edition (McGraw Hill Medical, 2025) - HHV-6 and HHV-7 chapter
• Red Book: 2021 Report of the Committee on Infectious Diseases (AAP) - Human Herpesvirus 6 (Including Roseola) and 7 chapter
• Dermatology 2-Volume Set, 5th Edition - HHV-6/Exanthem Subitum section
• Fitzpatrick's Dermatology - Human Herpesvirus 6 section
• Sherris & Ryan's Medical Microbiology, 8th Edition - Roseola Infantum chapter
• Jawetz, Melnick & Adelberg's Medical Microbiology, 28th Edition - HHV-6 and HHV-7 chapter
• Tintinalli's Emergency Medicine, A Comprehensive Study - Roseola Infantum section
• Textbook of Family Medicine, 9th Edition - Other Human Herpesviruses section
• Leung AKC, Lam JM, Barankin B, Leong KF, Hon KL. Roseola Infantum: An Updated Review. Curr Pediatr Rev. 2024;20(2):119-128. PMID 36411550
• Webb G et al. Diagnostic Dilemmas: HHV-6 Encephalitis in Immunocompetent Adults. Open Forum Infect Dis. 2024. PMID 39301106
• StatPearls - Roseola Infantum (NCBI Bookshelf)

---

"That concludes our 120-minute lecture on Roseola Infantum. This is a disease that every pediatric resident will encounter in their first month. The beauty of roseola is that it teaches you the core of pediatric clinical reasoning: trust the defervescence-rash sequence, know your differentials, counsel your parents well, and resist the urge to over-investigate. See you at the bedside!"

---